$0.42 +0.00 (0.71%)

VolitionRX Limited Common Stock (VNRX)

VolitionRX Limited (VNRX) is a biomedical company focused on developing blood-based diagnostic tests for the early detection of cancer. Utilizing proprietary technology, the company aims to provide minimally invasive, cost-effective screening tools to improve cancer diagnosis and patient outcomes.

🚫 VolitionRX Limited Common Stock does not pay dividends

Company News

Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • January 3, 2024

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Sig...

Penny Stocks To Buy: 6 Insider Picks Before 2023
PennyStocks • J. Samuel • December 21, 2022

Insiders are buying these penny stocks but are they worth the risk? The post Penny Stocks To Buy: 6 Insider Picks Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

VolitionRX Ltd (VNRX) Q3 2021 Earnings Call Transcript
The Motley Fool • [email protected] (Motley Fool Transcribers) • November 12, 2021

VNRX earnings call for the period ending September 30, 2021.